These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37195291)

  • 1. Therapy results in pediatric Hodgkin lymphoma - does less mean better? Experience from a single children's oncology center.
    Stankiewicz J; Kołtan A; Demidowicz E; Bartoszewicz N; Kołtan S; Czyżewski K; Richert-Przygońska M; Dębski R; Pogorzała M; Tejza B; Cisek J; Księżniakiewicz P; Jatczak-Gaca A; Marjańska A; Salamon M; Dąbrowska A; Urbańczyk A; Grześk E; Jaremek K; Łęcka M; Grochowska O; Styczyński J
    Ann Hematol; 2023 Aug; 102(8):2109-2117. PubMed ID: 37195291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: a children's oncology group report.
    Trippett TM; Schwartz CL; Guillerman RP; Gamis AS; Gardner S; Hogan S; London WB; Chen L; de Alarcon P
    Pediatr Blood Cancer; 2015 Jan; 62(1):60-4. PubMed ID: 25308760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children's oncology group trials.
    Kahn JM; Pei Q; Friedman DL; Kaplan J; Keller FG; Hodgson D; Wu Y; Appel BE; Bhatia S; Henderson TO; Schwartz CL; Kelly KM; Castellino SM
    Lancet Haematol; 2022 Jan; 9(1):e49-e57. PubMed ID: 34971582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of age on treatment results in children and adolescents with Hodgkin's disease].
    Balwierz W; Moryl-Bujakowska A; Depowska T; Klekawka T; Stanuch H; Matysiak M; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Raś M; Sońta-Jakimczyk D; Moszant A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Drozyńska E; Wysocki M; Kołtan A; Krawczuk-Rybak M; Stolarska M
    Przegl Lek; 2004; 61 Suppl 2():40-4. PubMed ID: 15686044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children's Oncology Group.
    Appel BE; Chen L; Buxton AB; Hutchison RE; Hodgson DC; Ehrlich PF; Constine LS; Schwartz CL
    J Clin Oncol; 2016 Jul; 34(20):2372-9. PubMed ID: 27185849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of children with nodular lymphocyte predominant Hodgkin lymphoma - a Children's Cancer and Leukaemia Group report.
    Hall GW; Katzilakis N; Pinkerton CR; Nicolin G; Ashley S; McCarthy K; Daw S; Hewitt M; Wallace WH; Shankar A
    Br J Haematol; 2007 Sep; 138(6):761-8. PubMed ID: 17760808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical pathologic characteristics and treatment outcomes of 19 relapsed pediatric B-cell lymphoma].
    Huang S; Jin L; Yang J; Duan YL; Zhang M; Zhou CJ; Ma XL; Zhang YH
    Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):748-753. PubMed ID: 29050112
    [No Abstract]   [Full Text] [Related]  

  • 8. Current approaches to the management of pediatric Hodgkin lymphoma.
    Freed J; Kelly KM
    Paediatr Drugs; 2010 Apr; 12(2):85-98. PubMed ID: 20218745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of anti-programmed cell death protein 1 antibody in children with refractory or relapsed Hodgkin lymphoma].
    Li Y; Duan YL; Huang M; Zhang L; Jin YG; Zhang XL; Wang X
    Zhonghua Er Ke Za Zhi; 2022 Jun; 60(6):573-577. PubMed ID: 35658365
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
    Shankar A; Hayward J; Kirkwood A; McCarthy K; Hewitt M; Morland B; Daw S
    Br J Haematol; 2014 May; 165(4):534-44. PubMed ID: 24754633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children's Oncology Group.
    Parikh RR; Kelly KM; Hodgson DC; Hoppe BS; McCarten KM; Karolczuk K; Pei Q; Wu Y; Cho SY; Schwartz C; Cole PD; Roberts K
    Int J Radiat Oncol Biol Phys; 2022 Mar; 112(4):890-900. PubMed ID: 34767937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study.
    Lynch RC; Cassaday RD; Smith SD; Fromm JR; Cowan AJ; Warren EH; Shadman MS; Shustov A; Till BG; Ujjani CS; Libby EN; Philip M; Coye H; Martino CN; Bhark SL; Morris K; Rasmussen H; Behnia S; Voutsinas J; Gopal AK
    Lancet Haematol; 2021 Aug; 8(8):e562-e571. PubMed ID: 34329577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience.
    Batgi H; Merdin A; Dal MS; Kızıl Çakar M; Yıldız J; Başçı S; Uncu Ulu B; Yiğenoğlu TN; Darçın T; Şahin D; Bakırtaş M; Tetik A; İskender D; Altuntaş F
    J Oncol Pharm Pract; 2020 Dec; 26(8):1857-1863. PubMed ID: 32098553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors and long-term outcome of autologous haematopoietic stem cell transplantation following a uniform-modified BEAM-conditioning regimen for patients with refractory or relapsed Hodgkin lymphoma: a single-center experience.
    Czyz A; Lojko-Dankowska A; Dytfeld D; Nowicki A; Gil L; Matuszak M; Kozlowska-Skrzypczak M; Kazmierczak M; Bembnista E; Komarnicki M
    Med Oncol; 2013; 30(3):611. PubMed ID: 23702734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of nodular lymphocyte predominant Hodgkin lymphoma in the modern era.
    King MT; Donaldson SS; Link MP; Natkunam Y; Advani RH; Hoppe RT
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):67-75. PubMed ID: 25863755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The incidence and treatment of the first relapse in children with Hodgkin's disease].
    Balwierz W; Moryl-Bujakowska A; Bogusławska-Jaworska J; Pisarek J; Raś M; Sońta-Jakimczyk D; Janik-Moszant A; Rokicka-Milewska R; Sopylo B; Kolakowska-Mrozowska B; Kołecki P; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Matysiak M; Newecka-Samól T
    Med Wieku Rozwoj; 2000; 4(1 Suppl 2):73-84. PubMed ID: 12021465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapsed and refractory Hodgkin lymphoma: transplantation strategies and novel therapeutic options.
    David KA; Mauro L; Evens AM
    Curr Treat Options Oncol; 2007 Oct; 8(5):352-74. PubMed ID: 18214690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and treatment of anaplastic large-cell lymphoma in children and adolescents: a retrospective multicenter survey study].
    ;
    Zhonghua Er Ke Za Zhi; 2017 Mar; 55(3):194-199. PubMed ID: 28273702
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hodgkin's lymphoma in adolescents: where to treat it--in an adult or pediatric institution?].
    Müller J; Molnár Z; Illés A; Csóka M; Jakab Z; Deák B; Schneider T; Várady E; Rosta A; Simon Z; Keresztes K; Gergely L; Kovács G
    Orv Hetil; 2008 Nov; 149(47):2221-7. PubMed ID: 19004744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study.
    Lazarovici J; Dartigues P; Brice P; Obéric L; Gaillard I; Hunault-Berger M; Broussais-Guillaumot F; Gyan E; Bologna S; Nicolas-Virelizier E; Touati M; Casasnovas O; Delarue R; Orsini-Piocelle F; Stamatoullas A; Gabarre J; Fornecker LM; Gastinne T; Peyrade F; Roland V; Bachy E; André M; Mounier N; Fermé C
    Haematologica; 2015 Dec; 100(12):1579-86. PubMed ID: 26430172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.